“Given the reduction in disabling stroke demonstrated in this trial, along with the feasibility and safety of using the CEP device, CEP should be considered for all patients undergoing TAVR.”
Building similarity graph...
Analyzing shared references across papers
Loading...
Samir Kapadia
Susheel Kodali
Raj Makkar
Journal of the American College of Cardiology
University of Washington
University of Pennsylvania
Washington University in St. Louis
Building similarity graph...
Analyzing shared references across papers
Loading...
Kapadia et al. (Tue,) studied this question.
www.synapsesocial.com/papers/6a0dd0e4954656309d752c0c — DOI: https://doi.org/10.1016/j.jacc.2016.10.023